HERSHBERG ROBERT

ADPT

HERSHBERG ROBERT serves as Director at Adaptive Biotechnologies Corporation (ADPT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$874.2K

Net Position

Net Seller

$874.2K

Companies Traded

ADPT, FATE

Active Period

Mar 2021 – Dec 2025

4 total trades

Most Recent

Sell ADPT

Dec 10, 2025 · $367.5K

HERSHBERG ROBERT's Insider Trading at Adaptive Biotechnologies Corporation (ADPT)

Buys

0 · $0.00

Sells

3 · $858.9K

Total Shares Bought

Total Shares Sold

77,968

ADPT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 10, 2025	Sell	22,968	$16.00	$367.5K
Mar 12, 2025	Sell	53,000	$7.59	$402.3K
Mar 8, 2021	Sell	2,000	$44.56	$89.1K

HERSHBERG ROBERT's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

0 · $0.00

Sells

1 · $15.3K

Total Shares Bought

Total Shares Sold

672

FATE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 6, 2022	Sell	672	$22.75	$15.3K	2,009

Related Insiders

ROBINS HARLAN S

officer: Chief Scientific Officer

ADPTSell · Jul 7, 2026

BOBULSKY SUSAN

officer: Chief Commercial Officer, MRD

ADPTSell · Jul 6, 2026

LO FRANCIS

officer: Chief People Officer

ADPTSell · Jul 6, 2026

BENZENO SHARON

officer: Chief Commercial Ofc Imm Med

ADPTSell · Jun 30, 2026

GRIFFIN MICHELLE RENEE

director

ADPTSell · Jun 29, 2026

Bahram Valamehr

President and CEO

FATESell · May 21, 2026

TAHL CINDY

See Remarks

FATESell · May 21, 2026

PISKEL KYLE

officer: Chief Financial Officer

ADPTSell · May 20, 2026

Explore More Insider Trading Data

ADPT Insider Trading Activity

View all insider trades at Adaptive Biotechnologies Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity